MEDX.SW SIX
medmix AG
1W: -2.5%
1M: +10.0%
3M: +21.4%
YTD: -17.3%
1Y: -9.9%
3Y: -56.1%
CHF 9.89 ($11.94)
+0.06 (+0.61%)
Weekly Expected Move ±4.8%
CHF 9
CHF 9
CHF 10
CHF 10
CHF 11
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$68M
-21.7% ▼
5Y CAGR: +6.0%
Capital Expenditures
$34M
+28.9% ▲
5Y CAGR: -4.4%
Free Cash Flow
$33M
-12.6% ▼
5Y CAGR: +34.7%
Dividends Paid
$15M
+0.0% ▲
Buybacks
$3M
-420.0% ▼
Net Change in Cash
-$13M
-0.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $44M | $12M | $700K | -$6M | $6M |
| Depreciation & Amort. | $51M | $50M | $55M | $62M | $52M |
| Stock-Based Comp. | $1M | $2M | $2M | $0 | $0 |
| Change in Working Capital | -$14M | -$48M | $1M | $35M | $1M |
| Other Non-Cash Items | $11M | $37M | -$4M | -$4M | $15M |
| Operating Cash Flow | $87M | $48M | $56M | $87M | $68M |
| — Investing Activities — | |||||
| Capital Expenditures | -$32M | -$39M | -$46M | -$38M | -$41M |
| Acquisitions (Net) | -$3M | -$17M | -$31M | -$4M | $400K |
| Investment Purchases | -$200K | -$3M | -$6M | $0 | $0 |
| Investment Sales | $31M | $300K | $3M | $0 | $0 |
| Other Investing | $100K | $1M | -$100K | -$8M | $0 |
| Investing Cash Flow | -$3M | -$57M | -$81M | -$52M | -$41M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$128M | $146M | -$124M | -$21M | -$3M |
| Stock Repurchased | -$6M | -$6M | -$3M | -$500K | -$3M |
| Dividends Paid | -$41M | -$15M | -$15M | -$15M | -$15M |
| Other Financing | -$7M | -$9M | -$12M | -$12M | -$16M |
| Financing Cash Flow | $112M | $116M | -$154M | -$49M | -$36M |
| Net Change in Cash | $195M | $104M | -$183M | -$12M | -$13M |
| Cash End of Period | $210M | $314M | $131M | $118M | $106M |
| Free Cash Flow | $55M | $9M | $3M | $38M | $33M |